Compare FOLD & PTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FOLD | PTEN |
|---|---|---|
| Founded | 2002 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.4B |
| IPO Year | 2007 | 1993 |
| Metric | FOLD | PTEN |
|---|---|---|
| Price | $10.17 | $6.19 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 10 |
| Target Price | ★ $30.29 | $7.25 |
| AVG Volume (30 Days) | 4.2M | ★ 7.5M |
| Earning Date | 11-04-2025 | 10-22-2025 |
| Dividend Yield | N/A | ★ 5.19% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $598,704,000.00 | ★ $4,837,946,000.00 |
| Revenue This Year | $21.49 | N/A |
| Revenue Next Year | $18.25 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 21.28 | N/A |
| 52 Week Low | $5.51 | $5.10 |
| 52 Week High | $10.79 | $9.58 |
| Indicator | FOLD | PTEN |
|---|---|---|
| Relative Strength Index (RSI) | 75.23 | 53.54 |
| Support Level | $9.73 | $6.07 |
| Resistance Level | $10.05 | $6.61 |
| Average True Range (ATR) | 0.37 | 0.26 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 99.54 | 66.39 |
Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.
Patterson-UTI Energy Inc is one of the substantial land rig drilling contractors in the United States. Its 2023 merger with NexTier greatly expanded its pressure pumping operations, as well, and the firm now controls nearly 20% of the North American market for drilling and completions services. The company operates under three reportable business segments: (i) drilling services, (ii) completion services, and (iii) drilling products. It also provides directional drilling services and tool rental services in united states onshore oil and gas basins.